Role of genetic and environmental factors in British twins with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 18, Issue 4, 2012, Pages 725-736

  Ng, Siew C ^a,c   Woodrow, Susannah ^a   Patel, Nisha ^a   Subhani, Javaid ^b   Harbord, Marcus ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b BASILDON HOSPITAL   (United Kingdom)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Concordance; Disease phenotype; Environmental factors; Infections; Inflammatory bowel disease; Twins

Indexed keywords

MERCAPTOPURINE; ORAL CONTRACEPTIVE AGENT; STEROID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; COLON CROHN DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; GASTROENTERITIS; HEMICOLECTOMY; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; MUMPS; ORAL CONTRACEPTION; PET ANIMAL; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SMOKING; STEROID THERAPY; TWIN CONCORDANCE; TWIN DISCORDANCE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANIMALS; CHILD; CONTRACEPTIVES, ORAL; DISEASES IN TWINS; FEMALE; GREAT BRITAIN; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MUMPS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SMOKING; TWINS; YOUNG ADULT;

EID: 84858693205     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21747     Document Type: Article

References (68)

1. Sartor RB, Muehlbauer M. Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr Gastroenterol Rep. 2007;9:497-507. (Pubitemid 351795708)
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347: 417-429. (Pubitemid 34851835)
3. Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988; 29:990-996.
4. Orholm M, Binder V, Sorensen TI, et al. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol. 2000;35:1075-1081.
5. Shih DQ, Targan SR, McGovern D. Recent advances in IBD pathogenesis: genetics and immunobiology. Curr Gastroenterol Rep. 2008;10: 568-575.
6. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066-2078.
7. Halfvarson J, Bodin L, Tysk C, et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology. 2003;124:1767-1773. (Pubitemid 36666773)
8. Halfvarson J, Jess T, Bodin L, et al. Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:1536-1544.
9. Thia KT, Loftus EV Jr, Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167-3182.
10. Halfvarson J, Jess T, Magnuson A, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish- Danish twin population. Inflamm Bowel Dis. 2006;12:925-933. (Pubitemid 44498280)
11. Guarner F. The intestinal flora in inflammatory bowel disease: normal or abnormal? Curr Opin Gastroenterol. 2005;21:414-418. (Pubitemid 40961166)
12. van der Heide F, Nolte IM, Kleibeuker JH, et al. Differences in genetic background between active smokers, passive smokers, and non-smokers with Crohn's disease. Am J Gastroenterol. 2010;105: 1165-1172.
13. Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462-1471. (Pubitemid 44687433)
14. Mahid SS, Minor KS, Stromberg AJ, et al. Active and passive smoking in childhood is related to the development of inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:431-438. (Pubitemid 46668248)
15. Jantchou P, Morois S, Clavel-Chapelon F, et al. Animal protein intake and risk of inflammatory bowel disease: the E3N Prospective Study. Am J Gastroenterol. 2010;105:2195-2201.
16. Baron S, Turck D, Leplat C, et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut. 2005;54:357-363. (Pubitemid 40299091)
17. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut. 1995;37:668-673.
18. Card T, Logan RF, Rodrigues LC, et al. Antibiotic use and the development of Crohn's disease. Gut. 2004;53:246-250. (Pubitemid 38125513)
19. Economou M, Pappas G. New global map of Crohn's disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14:709-720. (Pubitemid 351742998)
20. Koutroubakis IE, Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a metaanalysis of published case-control studies. Am J Gastroenterol. 2000;95:171-176. (Pubitemid 30041554)
21. Radford-Smith GL, Edwards JE, Purdie DM, et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut. 2002;51:808-813. (Pubitemid 35408600)
22. Reif S, Lavy A, Keter D, et al. Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease. Am J Gastroenterol. 2001;96:829-832. (Pubitemid 32240739)
23. Koutroubakis IE, Vlachonikolis IG, Kapsoritakis A, et al. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: case-controlled study in Crete. Dis Colon Rectum. 1999;42: 225-230. (Pubitemid 29085160)
24. Han DY, Fraser AG, Dryland P, et al. Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand. Mutat Res. 2010;690: 116-122.
25. Singh S, Graff LA, Bernstein CN. Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? Am J Gastroenterol. 2009;104: 1298-1313.
26. Bernstein CN, Singh S, Graff LA, et al. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010;105:1994-2002.
27. Halfvarson J, Jess T, Magnuson A, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish- Danish twin population. Inflamm Bowel Dis. 2006;12:925-933. (Pubitemid 44498280)
28. Cederlof R, Friberg L, Jonsson E, et al. Studies on similarity diagnosis in twins with the aid of mailed questionnaires. Acta Genet Stat Med. 1961;11:338-362.
29. Spehlmann ME, Begun AZ, Burghardt J, et al. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis. 2008;14:968-976.
30. Gearry RB, Richardson AK, Frampton CM, et al. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25:325-333.
31. Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut. 1988; 29:990-996.
32. Bayless TM, Tokayer AZ, Polito JM, et al. Crohn's disease: concordance for site and clinical type in affected family members-potential hereditary influences. Gastroenterology. 1996;111:573-579. (Pubitemid 26293219)
33. Peeters M, Nevens H, Baert F, et al. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology. 1996;111:597-603. (Pubitemid 26293222)
34. Colombel JF, Grandbastien B, Gower-Rousseau C, et al. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology. 1996; 111:604-607. (Pubitemid 26293223)
35. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology. 2002;122:854-866. (Pubitemid 34267267)
36. Abreu MT, Taylor KD, Lin YC, et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology. 2002;123:679-688. (Pubitemid 34977073)
37. Vermeire S, Pierik M, Hlavaty T, et al. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD. Gastroenterology. 2005;129:1845-1853. (Pubitemid 41772963)
38. Ho GT, Nimmo ER, Tenesa A, et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology. 2005;128:288-296. (Pubitemid 40431082)
39. Singh SM, Murphy B, O'Reilly R. Epigenetic contributors to the discordance of monozygotic twins. Clin Genet. 2002;62:97-103. (Pubitemid 36372705)
40. Persson PG, Ahlbom A, Hellers G. Crohn's disease and ulcerative colitis. A review of dietary studies with emphasis on methodologic aspects. Scand J Gastroenterol. 1987;22:385-389. (Pubitemid 17072149)
41. Feeney MA, Murphy F, Clegg AJ, et al. A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002;14:529-534. (Pubitemid 34518185)
42. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second-generation South Asians in Leicester (1991-1994). Am J Gastroenterol. 1999;94:2918-2922. (Pubitemid 29482758)
43. Probert CS, Jayanthi V, Pinder D, et al. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut. 1992;33:687-693.
44. Somerville KW, Logan RF, Edmond M, et al. Smoking and Crohn's disease. Br Med J (Clin Res Ed). 1984;289:954-956. (Pubitemid 14011155)
45. Lashner BA, Shaheen NJ, Hanauer SB, et al. Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children. Am J Gastroenterol. 1993;88:356-359. (Pubitemid 23085841)
46. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr. 1999;69:1035S-1045S. (Pubitemid 29205082)
47. Zoetendal EG, von WA, Vilpponen-Salmela T, et al. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002;68:3401-3407.
48. Cucchiara S, Iebba V, Conte MP, et al. The microbiota in inflammatory bowel disease in different age groups. Dig Dis. 2009;27:252-258.
49. Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis. 2009;22:292-301.
50. Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med. 2008;263:597-606. (Pubitemid 351678591)
51. Amre DK, Lambrette P, Law L, et al. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am J Gastroenterol. 2006;101:1005-1011. (Pubitemid 43725314)
52. Ekbom A, Adami HO, Helmick CG, et al. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol. 1990;132:1111-1119.
53. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010;105:2687-2692.
54. Hviid A, Svanstrom H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut. 2011;60:49-54.
55. Nielsen LL, Nielsen NM, Melbye M, et al. Exposure to measles in utero and Crohn's disease: Danish register study. BMJ. 1998;316: 196-197. (Pubitemid 28122256)
56. Morgan-Capner P, Wright J, Miller CL, et al. Surveillance of antibody to measles, mumps, and rubella by age. BMJ. 1988;297:770-772.
57. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb-C/ 1195733851374.
58. Bernstein CN, Rawsthorne P, Blanchard JF. Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:759-762. (Pubitemid 46909992)
59. Radon K, Windstetter D, Poluda AL, et al. Contact with farm animals in early life and juvenile inflammatory bowel disease: a case-control study. Pediatrics. 2007;120:354-361. (Pubitemid 47219506)
60. Radon K, Windstetter D, Poluda D, et al. Exposure to animals and risk of oligoarticular juvenile idiopathic arthritis: a multicenter case-control study. BMC Musculoskelet Disord. 2010;11:73.
61. Bernstein CN, Rawsthorne P, Cheang M, et al. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol. 2006;101:993-1002. (Pubitemid 43725312)
62. Cashman KD, Shanahan F. Is nutrition an aetiological factor for inflammatory bowel disease? Eur J Gastroenterol Hepatol. 2003;15: 607-613. (Pubitemid 36688223)
63. Asakura H, Suzuki K, Kitahora T, et al. Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis? J Gastroenterol Hepatol. 2008;23:1794-1801.
64. Cornish JA, Tan E, Simillis C, et al. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103:2394-2400.
65. Lakatos PL. Environmental factors affecting inflammatory bowel disease: have we made progress? Dig Dis. 2009;27:215-225.
66. Gent AE, Hellier MD, Grace RH, et al. Inflammatory bowel disease and domestic hygiene in infancy. Lancet. 1994;343:766-767.
67. Duggan AE, Usmani I, Neal KR, et al. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut. 1998;43:494-498. (Pubitemid 28462034)
68. Declercq C, Gower-Rousseau C, Vernier-Massouille G, et al. Mapping of inflammatory bowel disease in northern France: spatial variations and relation to affluence. Inflamm Bowel Dis. 2010;16:807-812.